In order to further verify the ability of HK3 as a tumor marker of ccRCC, we collected clinicopathological characteristics baseline in relation to HK3 mRNA expression status in 910 ccRCC patients from TCGA and FUSCC cohorts. Here, HK3 is linked to neoplasm.